Validation and development of N-glycan as biomarker in cancer diagnosis

Current Pharmacogenomics and Personalized Medicine

Volumn 11, Issue 1, 2013, Pages 53-58

  Wang, Wei ^a,b,c  

^a EDITH COWAN UNIVERSITY   (Australia)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Cancer biomarker; Glycomics; N glycan; Oligosaccharide; Personalized medicine; Public health pharmacogenomics

Indexed keywords

BIOLOGICAL MARKER; GLYCAN; TUMOR MARKER;

ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; COLORECTAL CANCER; ENZYME LINKED IMMUNOSORBENT ASSAY; FUCOSYLATION; GLYCOBIOLOGY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MULTIPLE MYELOMA; OVARY CANCER; PROTEIN STRUCTURE; SENSITIVITY AND SPECIFICITY; SIALYLATION;

EID: 84876729013     PISSN: 18756921     EISSN: 18756913     Source Type: Journal    
DOI: 10.2174/1875692111311010008     Document Type: Article

References (47)

1. Alikhani Z, Alikhani M, Boyd CM, et al. Advanced glycation end products enhance expression of pro-apoptotic genes and stimulate fibroblast apoptosis through cytoplasmic and mitochondrial pathways. J Biol Chem 2005; 280: 12087-95.
2. Phan UT, Waldron TT, Springer TA. Remodeling of the lectin-EGF-like domain interface in P-and L-selectin increases adhesiveness and shear resistance under hydrodynamic force. Nat Immunol 2006; 7: 883-9.
3. Gewinner C, Hart G, Zachara N, et al. The coactivator of transcription CREB-binding protein interacts preferentially with the glycosylated form of Stat5. J Biol Chem 2004; 279: 3565-72.
4. Choudhury A, Moniaux N, Ulrich AB, et al. MUC4 mucin expression in human pancreatic tumours is affected by organ environment: the possible role of TGFbeta2. Br J Cancer 2004; 90: 657-64.
5. Hakomori S. Inaugural Article: The glycosynapse. Science's STKE 2002; 99: 225-32.
6. Partridge E, Le Roy C, Di Guglielmo G, et al. Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis. Science 2004; 1306: 120-4.
7. Knezevic A, Polasek O, Gornik O, et al. Variability, Heritability and Environmental Determinants of Human Plasma N-Glycome. J Proteome Res 2009; 8: 694-701.
8. Peracaula R, Barrabés S, Sarrats A, et al. Altered glycosylation in tumours focused to cancer diagnosis. Dis Markers 2008; 25: 207-18.
9. Izawa M, Kumamoto K, Mitsuoka C, et al. Expression of sialyl 6-sulfo Lewis X is inversely correlated with conventional sialyl Lewis X expression in human colorectal cancer. Cancer Res 2000; 60: 1410-6.
10. Liu F, Zhang Y, Zhang X, et al. Transfection of the nm23-H1 gene into human hepatocarcinoma cell line inhibits the expression of sialyllewis X, a1, 3 fucosyltransferase VII, and metastatic potential. J Cancer Res Clin Oncol 2002; 128: 189-96.
11. Zhao J, Qiu W, Simeone D, et al. N-linked Glycosylation Profiling of Pancreatic Cancer Serum Using Capillary Liquid Phase Separation Coupled with Mass Spectrometric Analysis. J Proteome Res 2007; 6: 1126-38.
12. Peracaula R, Tabares G, Royle L, et al. Altered glycosylation pattern allows the distinction between prostate-specific antigen (PSA) from normal and tumor origins. Glycobiology 2003; 13: 457-70.
13. Kyselova Z, Mechref Y, Kang P, et al. Breast Cancer Diagnosis and Prognosis through Quantitative Measurements of Serum Glycan Profiles. Clin Chem 2008; 54: 1166-75.
14. Ueda K, Katagiri T, Shimada T, et al. Comparative Profiling of Serum Glycoproteome by Sequential Purification of Glycoproteins and 2-Nitrobenzenesulfenyl (NBS) Stable Isotope Labeling: A New Approach for the Novel Biomarker Discovery for Cancer. J Proteome Res 2007; 6: 3475-83.
15. Saldova R, Royle L, Radcliffe C, et al. Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG. Glycobiology 2007; 17: 1344-56.
16. Vanhooren V, Laroy W, Libert C, et al. N-Glycan profiling in the study of human aging. Biogerontology 2008; 9: 351-6.
17. Varki A, Cummings R, Esko J, et al. Essentials of glycobiology. Cold spring Harbor Laboratory Press. 1999.
18. Durand G, Seta N. Protein Glycosylation and Diseases: Blood and Urinary Oligosaccharides as Markers for Diagnosis and Therapeutic Monitoring. Clin Chem 2000; 46: 795-805.
19. Jianmin Wu. Reconsideration of tumor marker. Zhong Hua Jian Yan Yi Xue Za Zhi (in Chinese) 2005; 28: 11-3.
20. Manne U, Srivastava RG, Srivastava S. Recent advances in biomarkers for cancer diagnosis and treatment. Drug Discov Today 2005; 10: 965-76.
21. Gornik O, Wagner J, Pui M, et al. Stability of N-glycan profiles in human plasma. Glycobiology 2009; 19: 1547-53.
22. Akira Kobata. Glycobiology in the field of aging research- introduction to glycogerontology. Biochimie 2003; 85: 13-24.
23. Vanhooren V, Liu X, Franceschi C, et al. N-glycan profiles as tools in diagnosis of hepatocellular carcinomaand prediction of healthy human ageing. Mech Ageing Dev 2009; 130: 92-7.
24. Pucic M, Pinto S, Novokmet M, et al. Common aberrations from the normal human plasma N-glycan profile. Glycobiology 2010; 20: 970-5.
25. Rye P, Walker R. Analysis of glycoproteins released from benign and malignant human breast: changes in size and fucosylation with malignancy. Eur J Cancer Clin Oncol 1989; 25: 65-72.
26. Qiu Y, Patwa T, Xu L, et al. Plasma Glycoprotein in Profiling for Colorectal Cancer Biomarker Identification by LectinGlycoarray and Lectin Blot. J Proteome Res 2008; 7: 1693-703.
27. Kam R, Poon T, Chan H, et al. High-Throughput Quantitative Profiling of Serum N-Glycome by MALDI-TOF Mass Spectrometry and N-Glycomic Fingerprint of Liver Fibrosis. Clin Chem 2007; 53: 1254-63.
28. Liu X, Desmyter L, Gao C, et al. N-Glycomic Changes in Hepatocellular Carcinoma Patients with Liver Cirrhosis Induced by Hepatitis B Virus. Hepatology 2007; 46: 1426-35.
29. Norton P, Comunale M, Krakover J, et al. N-Linked Glycosylation of the Liver Cancer Biomarker GP73. J Cell Biochem 2008; 104: 136-49.
30. Tang Z, Varghese R, Bekesova S, et al. Identification of N-glycan serum markers associated with hepatocellular carcinoma from mass spectrometry data. J Proteome Res 2010; 9: 104-12.
31. Block T, Comunale M, Lowman M, et al. Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans. Proc Natl Acad Sci USA 2005; 102: 779-84.
32. Liu X, Dewaele S, Vanhooren V, et al. Alteration of N-glycome in diethylnitrosamine-induced hepatocellular carcinoma mice: a noninvasive monitoring tool for liver cancer. Liver Int 2010; 30: 1221-8.
33. An H, Miyamoto S, Lancaster K, et al. Profiling of Glycans in Serum for the Discovery of Potential Biomarkers for Ovarian Cancer. J Proteome Res 2006; 5: 1626-35.
34. Leiserowitz G, Lebrilla C, Miyamoto S, et al. Glycomics analysis of serum a potential new biomarker for ovarian cancer. Int J Gynecol Cancer 2008; 18: 470-5.
35. Gornik O, Royle L, Harvey D, et al. Changes of serum glycans during sepsis and acute pancreatitis. Glycobiology 2007; 17: 1321-32.
36. Royle L, Campbell M, Radcliffe C, et al. HPLC-based analysis of serum N-glycans on a 96-well plate platform with dedicated database software. Anal Biochem 2008; 376: 1-12.
37. Abbott K, Aoki K, Lim J, et al. Targeted Glycoproteomic Identification of Biomarkers for Human Breast Carcinoma. J Proteome Res 2008; 7: 1470-80.
38. Arnold J, Saldova R, Hamid U, et al. Evaluation of the serum Nlinked glycome for the diagnosis of cancer and chronic inflammation. Proteomics 2008; 8: 3284-93.
39. Lee Y, Lin T. Determination of carbohydrates by high-performance capillary electrophoresis with indirect absorbance detection. J Chromatogr B Biomed Appl 1996; 681: 87-97.
40. Kolarich D, Altmann F. N-Glycan Analysis by Matrix-Assisted Laser Desorption/ Ionization Mass Spectrometry of Electrophoretically Separated Nonmammalian Proteins: Application to Peanut Allergen Ara h 1 and Olive Pollen Allergen Ole e 1. Anal Biochem 2000; 285: 64-75.
41. Kim Y, Jeong H, Jang K, et al. Rapid and high-throughput analysis of N-glycans from ovarian cancer serum using a 96-well plate platform. Anal Biochem 2009; 391: 151-3.
42. Kirmiz C, Li B, An H, et al. A serum glycomics approach to breast cancer biomarkers. Mol Cell Proteomics 2007; 6: 43-55.
43. Chu C, Nionuevo M, Clowers B, et al. Profile of Native N-linked Glycan Structures from Human Serum Using High Performance Liquid Chromatography on a Microfluidic Chip and Time-of-Flight Mass Spectrometry. Proteomics 2009; 9: 1939-51.
44. Lu, JP, Knezevic A, Wang YX, et al. Screening novel biomarkers for metabolic syndrome by profiling human plasma N-glycans in Chinese Han and Croatian populations. J Proteome Res 2011; 10(11): 4959-69.
45. Lu JP, Huang Y, Wang YX, et al. Profiling Plasma Peptides for the Identification of Potential Ageing Biomarkers in Chinese Han Adults. PLoS ONE 2012; 7(7): e39726.
46. Lv S, Xu Y, Chen X, et al. Prioritizing Cancer Therapeutic Small Molecules by Integrating Multiple OMICS Datasets. OMICS 2012; 16(10): 552-9.
47. Lauc G, Huffman JE, Pučić M, Zgaga L, et al. Loci associated with N-glycosylation of human immunoglobulin G show pleiotropy with autoimmune diseases and haematological cancers. PLoS Genet, 2013; 9(1): e1003225.